Long-term relationship between everolimus blood concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma: a prospective study

Abstract Background Everolimus is an oral inhibitor of mammalian target of rapamycin, approved for metastatic renal cell carcinoma (mRCC). Recently, personalized medicine through therapeutic drug monitoring (TDM) is recommended in cancer therapy. In this study, the relationship between everolimus bl...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinya Takasaki (Author), Hiroaki Yamaguchi (Author), Yoshihide Kawasaki (Author), Masafumi Kikuchi (Author), Masaki Tanaka (Author), Akihiro Ito (Author), Nariyasu Mano (Author)
Format: Book
Published: BMC, 2019-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available